Allison Greenfield co-leads the discovery and development practice at Klein Hersh International. Her core expertise spans a broad range of therapeutic areas, including oncology, immune-oncology, inflammation and autoimmunity, cardiovascular and metabolism, and infectious diseases, as well as cell therapy, gene therapy, gene editing, base editing, biotherapeutics, and antibody drug conjugates (ADCs).
As the co-leader of the discovery and development practice, Allison’s responsibilities include:
- Partnering with seed-stage companies, small-to-mid-sized biotech companies, and large pharmaceutical companies on the recruitment of professionals in discovery, preclinical, and translational research
Since joining Klein Hersh in 2006, Allison has been focused on advancing the long-term visions of the companies she partners with, helping build the teams that drive the scientific discoveries that improve human health. Clients who partner with Allison can expect a high-touch personalized experience with rapid presentation of industry leaders meeting the criteria set forth in a search. She values the opportunity to making a lasting impact on every client - and every candidate - that she meets.